CDKN2A and cancer: However, CDKN2A, LUM, CDHR5, and COLEC12 contribute to important cancer-related enrichment pathways, such as “TGF-beta regulation of extracellular matrix.” Full details of these enrichment analyses are available in Supplementary Table S6.